These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3745986)

  • 21. Pharmacologic effect of recombinant human IFN-alpha, continuously released from a matrix prepared from a polyglycerol ester of fatty acids, on 2',5'-oligoadenylate synthetase activity in murine liver.
    Yamagata Y; Yuasa Y; Yamamoto K; Okamoto K; Igari Y; Iga K; Ogawa Y
    J Interferon Cytokine Res; 2000 Feb; 20(2):153-60. PubMed ID: 10714550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian dependence of interferon antitumor activity in mice.
    Koren S; Whorton EB; Fleischmann WR
    J Natl Cancer Inst; 1993 Dec; 85(23):1927-32. PubMed ID: 8230283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperthermia effects on the growth of a laryngeal squamous cell carcinoma cell line treated with recombinant human interferons alpha and gamma.
    Park RI; Richtsmeier WJ
    Otolaryngol Head Neck Surg; 1989 Nov; 101(5):542-8. PubMed ID: 2512532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of rHuIFN-alpha A/D on brain lipids and behavior of neonatal ICR Swiss albino mice.
    Myers-Kazimer R; Wilson MS; Mervis RF; Yates AJ
    J Interferon Res; 1989 Feb; 9(1):11-21. PubMed ID: 2715668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined effect of human recombinant interferon alpha, beta and gamma on tumor cell growth and the cell cycle in vitro].
    Kondo H; Tanaka N; Naomoto Y; Orita K
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1234-9. PubMed ID: 3107476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential antiproliferative effects of combinations of recombinant interferons alpha and gamma on two murine tumor cell lines.
    Brunda MJ; Wright RB
    Int J Cancer; 1986 Feb; 37(2):287-91. PubMed ID: 3080378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers.
    Salmon P; Le Cotonnec JY; Galazka A; Abdul-Ahad A; Darragh A
    J Interferon Cytokine Res; 1996 Oct; 16(10):759-64. PubMed ID: 8910759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential antiproliferative activities of IFNs alpha, beta and gamma: kinetics of establishment of their antiproliferative effects and the rapid development of resistance to IFNs alpha and beta.
    Fleischmann CM; Fleischmann WR
    J Biol Regul Homeost Agents; 1988; 2(4):173-85. PubMed ID: 3150645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Morphological changes of human neuroblastoma cells induced by human gamma interferon].
    Imanishi J; Watanabe H; Hiratani H; Tanaka A; Nakayama K; Chisaka T; Sugimoto T
    C R Seances Soc Biol Fil; 1987; 181(1):94-9. PubMed ID: 2954628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
    Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL
    J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-alpha and -gamma in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell lines.
    Hand AM; Husgafvel-Pursiainen K; Pelin K; Vallas M; Suitiala T; Ekman A; Mattson M; Mattson K; Linnainmaa K
    Anticancer Drugs; 1992 Dec; 3(6):687-94. PubMed ID: 1288739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
    Gridley DS; Slater JM; Stickney DR
    J Biol Response Mod; 1989 Dec; 8(6):593-602. PubMed ID: 2513378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity.
    Byrne GI; Lehmann LK; Kirschbaum JG; Borden EC; Lee CM; Brown RR
    J Interferon Res; 1986 Aug; 6(4):389-96. PubMed ID: 3095441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of interferon-induced antiviral states: contrasting profiles of decay in response to the removal of MuIFN-alpha, MuIFN-beta and MuIFN-gamma.
    Ramamurthy V; Fleischmann WR
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1645-52. PubMed ID: 3016159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons.
    Belardelli F; Gessani S; Proietti E; Locardi C; Borghi P; Watanabe Y; Kawade Y; Gresser I
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2203-12. PubMed ID: 3039046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hyperthermia on the antiproliferative activities of murine alpha-, beta-, and gamma-interferon: differential enhancement of murine gamma-interferon.
    Fleischmann WR; Fleischmann CM; Gindhart TD
    Cancer Res; 1986 Jan; 46(1):8-13. PubMed ID: 2998611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of pharmacokinetic behaviors of two human interferons (Lb-IFN-alpha and Re-IFN-alpha A) in cynomolgus monkeys by 2'-5' oligoadenylate synthetase assay.
    Bannai H
    Jpn J Med Sci Biol; 1986; 39(5-6):185-98. PubMed ID: 3599526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibition of colony formation by a human tumor degenerating factor (TDF); enhancement of this effect by interferons].
    Imanishi J; Tanaka A; Matsuoka H; Kakui Y; Uemura H; Imanishi T; Nishino H
    C R Seances Soc Biol Fil; 1986; 180(5):596-600. PubMed ID: 2950983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of in vivo potentiation resulting from combined interferon therapy: antitumor effect against B-16 melanoma in mice.
    Koren S; Fleischmann WR
    J Interferon Res; 1986 Oct; 6(5):473-82. PubMed ID: 2433361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid recombinant human leukocyte interferon inhibits differentiation in murine B-16 melanoma cells.
    Fisher PB; Hermo H; Prignoli DR; Weinstein IB; Pestka S
    Biochem Biophys Res Commun; 1984 Feb; 119(1):108-15. PubMed ID: 6704115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.